[6] In 2008, Dipp worked with Christoph Westphal, Richard Aldrich, and Alexey Margolin to found Alnara Pharmaceuticals, which was created to develop ways to formulate biopharmaceuticals so they could be taken by mouth, instead of by injection.
[13] In October 2017 Dipp became the Managing Director at General Atlantic,[14][12] a global growth equity firm based in New York City.
[15] In 2020, Dipp founded Biospring Partners with Jennifer Lum to conduct venture capital in the life sciences industry.
Investments for Biospring Partners include funding for Abzena[16] who were subsequently selected to work on the antibody cocktail for COVID 19 treatment.
[17] On June 30, 2020, the Securities and Exchange Commission announced that Michelle Dipp, a co-founder and former CEO of the now defunct OvaScience, Inc., agreed to settle fraud charges for misleading investors about the availability and commercial prospects for the company’s fertility treatments that were in development.